Regulus Therapeutics | RGLS - الأصول



الأصول تغيير تاريخ
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
AstraZeneca USD 114.07B 382M 2025-12
Biogen USD 29.44B 232M 2025-12
Celldex Therapeutics USD 582.98M 65.46M 2025-12
Cipla INR 401.64B 27.77B 2025-09
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 156.57M 58.73M 2025-12
CSL USD 37.9B 1.5B 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
Grifols EUR 23.15B 142.7M 2025-12
Immunic USD 40.7M 20.72M 2025-09
Incyte USD 6.96B 627.62M 2025-12
Intrexon USD 73.16M 77.88M 2024-06
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
Lexicon Pharmaceuticals USD 184.99M 20.94M 2025-12
Ligand Pharmaceuticals USD 1.56B 83.86M 2025-12
Merck USD 129.55B 12.02B 2025-09
Omeros USD 200.57M 34.59M 2025-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sanofi EUR 126.81B 25.48B 2025-12
Takeda JPY 15.41T 938.47B 2025-12